10 Biggest Mid-Day Gainers For Thursday - Cara Therapeutics (NASDAQ:CARA), AEterna Zentaris (NASDAQ:AEZS)

ContraVir Pharmaceuticals Inc CTRV shares jumped 21.6 percent to $1.35 after the company disclosed positive interim data for CMX157 from its Phase 2a clinical study.
AEterna Zentaris Inc. (USA) AEZS shares surged 19.7 percent to $4.55. AEterna Zentaris shares have slipped 45.71 percent over the past 52 weeks, while the S&P 500 index has gained 6.76 percent in the same period.
Ocular Therapeutix Inc OCUL shares climbed 16.6 percent to $7.36 after the company revealed a tactical collaboration, option and license deal with Regeneron Pharmaceuticals Inc REGN. Ocular stock surged more than 25 percent. According to the agreement terms, the two companies would develop a sustained release formulation of aflibercept, which fits properly for clinical development advancement.
Lindsay Corporation LNN gained 11.8 percent to $77.50. Lindsay reported Q4 earnings of $0.73 per share on revenue of $132.9 million.
PICO Holdings Inc PICO shares rose 9.6 percent to $11.82. PICO reported the conclusion of Synthonics investigation and disclosed that its board has terminated John Hart as CEO of the company and Vidler Water.
Esperion Therapeutics Inc ESPR shares climbed 9.6 percent to $13.50. Esperion Therapeutics disclosed that bempedoic acid global Phase 3 clinical program will include patients on any statin at any dose. The 1002-035 study also met its primary endpoint.
Long Island Iced Tea Corp LTEA shares gained 9.3 percent to $5.06 after the company disclosed that it has entered into a partnership with Food Lion LLC.
Ulta Salon, Cosmetics & Fragrance, Inc. ULTA surged 8.5 percent to $259.19 after the company boosted its EPS and comparable store sales forecast for the third quarter and full year.
Cara Therapeutics Inc CARA shares gained 5.7 percent to $7.99. H.C. Wainwright initiated coverage on Cara Therapeutics with a Buy rating.
HCA Holdings Inc HCA shares rose 3.1 percent to $79.24. KeyBanc upgraded HCA Holdings from Sector Weight to Overweight.

Market News and Data brought to you by Benzinga APIs